Phase I dose-escalation study of brentuximab-vedotin combined with dexamethasone, high-dose cytarabine and cisplatin, as salvage treatment in relapsed/refractory classical Hodgkin lymphoma: The HOVON/LLPC Transplant BRaVE study

Anton Hagenbeek, Hans Mooij, Josée Zijlstra, Pieternella Lugtenburg, Gustaaf van Imhoff, Marcel Nijland, Sanne Tonino, Martin Hutchings, Marjolein Spiering, Roberto Liu, Harm van Tinteren, Marie José Kersten

    Research output: Contribution to journalLetterAcademicpeer-review

    16 Citations (Scopus)
    47 Downloads (Pure)
    Original languageEnglish
    Pages (from-to)e151-e153
    Number of pages3
    Issue number4
    Publication statusPublished - 31-Mar-2019

    Cite this